Lowenol AHL-U

Diaminopyrimidine Oxide. Lowenol AHL-U distributed by DKSH inhibits lysyl hydroxylase enzyme (LH) mRNA expression, interfering with fibroblast collagen production and prevents mature collagen deposition, thereby preventing hair follicle hardening and contraction-induced hair loss.

• Compared to other hair loss treatments, it does not affect blood pressure, offering enhanced safety.
• Lowenol AHL-U also inhibits the activity of 5α-reductase, thereby reducing the conversion of testosterone to dihydrotestosterone (DHT), preventing hair follicle miniaturization.
• Clinical testing confirms significant hair loss reduction, improvement of local hair count, hair density, and hair diameter.
• It is available in USA.